Neutrophil-to-lymphocyte ratio and CD40 as diagnostic biomarkers for systemic lupus erythematosus and its disease activity

中性粒细胞与淋巴细胞比值和CD40作为系统性红斑狼疮及其疾病活动的诊断生物标志物

阅读:2

Abstract

OBJECTIVES: To evaluate the diagnostic value of the neutrophil-to-lymphocyte ratio (NLR), CD40, and other clinical indicators in systemic lupus erythematosus (SLE). METHODS: A retrospective study was conducted with 158 SLE patients treated at Xijing Hospital. The SLE group was divided into an active group (n = 95) and a low-activity group (n = 63). A control group consisting of 105 healthy individuals was also included. NLR, CD40, and other relevant clinical indicators were collected from the medical record system. The diagnostic or differential value of these indicators for SLE or disease activity (high vs. low) was assessed using ROC curves. Pearson correlation coefficients were used to examine the correlations between NLR, CD40, C-reactive protein (CRP), red blood cell distribution width (RDW), monocyte-to-lymphocyte ratio (MLR), and the SLE Disease Activity Index (SLEDAI) score. RESULTS: NLR and CD40 levels were significantly elevated in the SLE group (P < 0.001), with respective AUC values for diagnosing SLE of 0.917 and 0.907. NLR and CD40 levels in the SLE group were positively correlated with CRP and RDW, and negatively correlated with MLR (both P < 0.001). Furthermore, NLR and CD40 levels in the active SLE group were significantly higher than those in the low-activity group (P < 0.001), with AUC values for diagnosing disease activity of 0.902 and 0.904, respectively. SLEDAI scores were positively correlated with NLR and CD40 levels (P < 0.001). CONCLUSIONS: Both NLR and CD40 demonstrate high diagnostic value for SLE and disease activity assessment, suggesting their potential for clinical application in SLE diagnosis and management.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。